Publication
Title
Exploring virulence factors and alternative therapies against Staphylococcus aureus pneumonia
Author
Abstract
Pneumonia is an acute pulmonary infection associated with high mortality and an immense financial burden on healthcare systems. Staphylococcus aureus is an opportunistic pathogen capable of inducing S. aureus pneumonia (SAP), with some lineages also showing multidrug resistance. Given the high level of antibiotic resistance, much research has been focused on targeting S. aureus virulence factors, including toxins and biofilm-associated proteins, in an attempt to develop effective SAP therapeutics. Despite several promising leads, many hurdles still remain for S. aureus vaccine research. Here, we review the state-of-the-art SAP therapeutics, highlight their pitfalls, and discuss alternative approaches of potential significance and future perspectives.
Language
English
Source (journal)
Toxins
Publication
Basel : Mdpi , 2020
DOI
10.3390/TOXINS12110721
Volume/pages
12 :11 (2020) , 31 p.
Article Reference
721
ISI
000593691100001
Pubmed ID
33218049
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Project info
Combatting bacterial resistance in Europe (COMBACTE-NET).
Methicillin-resistant Staphylococcus au reus (MRSA}: Development of in vitro and in vivo laboratory models as predictive bridge between in vitro drug discovery and clinical evaluation.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 05.01.2021
Last edited 17.12.2024
To cite this reference